Works matching IS 18696953 AND DT 2022 AND VI 13 AND IP 7


Results: 10
    1
    2
    3
    4

    Efficacy, Safety, and Immunogenicity of Biosimilar Insulin Aspart Premix SAR341402 Mix 70/30 Compared with Originator Insulin Aspart Mix 70/30 in Adults with Diabetes (GEMELLI M): A Subgroup Analysis by Prior Type of Premix Insulin.

    Published in:
    Diabetes Therapy, 2022, v. 13, n. 7, p. 1299, doi. 10.1007/s13300-022-01279-z
    By:
    • Aravind, S. R.;
    • Singh, Kiran P.;
    • Mogylnytska, Liliia;
    • Zalevskaya, Alsu G.;
    • Matyjaszek-Matuszek, Beata;
    • Wernicke-Panten, Karin;
    • Nguyên-Pascal, My-Liên;
    • Pierre, Suzanne;
    • Rotthaeuser, Baerbel;
    • Kramer, Daniel;
    • Mukherjee, Bhaswati
    Publication type:
    Article
    5
    6
    7
    8
    9
    10